Mylan Asks Supreme Court To Review Notice Provision In Sandoz’s Patent Drug Suit
WASHINGTON, D.C. — Mylan Inc. in a March 21 an amicus curiae brief asks the U.S. Supreme Court to grant Sandoz Inc.’s petition to review whether an appellate court erred in...To view the full article, register now.
Already a subscriber? Click here to view full article